Associations of Tumor Somatic Mutations and Genetic Alterations with Survival Outcomes in Melanoma Patients Treated with Ipilimumab.

J Clin Med · 2026 · PMC13026618 · PMID 41899279

Europe PMC DOI

hedged sentence

0.4700

closest p · 9.4× alpha

0.4700

boldest claim

The sentences

did not reach statistical significancep = 0.47not close (p > 0.1)

In the present study ( Figure 5 ), we found that patients who developed rash as an immune-related adverse event (irAE) exhibited longer OS and RFS compared with those who did not develop rash following ipilimumab; however, these differences did not reach statistical significance (OS: p = 0.47; RFS: p = 0.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.